GRAIL (NASDAQ:GRAL) reported quarterly earnings results on February 19, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-2.44, beating the consensus estimate of $-2.93 by $0.49 per share. Revenue came in at $43.6M, beating the estimate of $43.5M.
GRAIL's stock moved following the earnings release. The stock currently trades at $50.21 with a market capitalization of $3.3B.


